Table of contents
October 2005 Volume 2 No 10
Top of page
Editorial
Top of page
Viewpoint
Top of page
Research Highlights
Positive family history as a risk factor for congenital heart disease
494Locations of plaque rupture in coronary arteries
495Similar clinical benefits with dual-chamber and single-chamber pacemakers
495Improved myocardial reperfusion with X-Sizer® thrombectomy
496New study allays concerns about increased thrombogenicity with drug-eluting stents
496Insulin resistance might link obesity and congestive heart failure
497Link between insulin resistance, ethnicity and endothelial dysfunction
498Vegetation length predicts new embolic events and mortality in infective endocarditis
498Top of page
Practice Points
Does clopidogrel provide additional benefit to aspirin and fibrinolytic therapy in patients after STEMI?
500Can valsartan reduce the occurrence of atrial fibrillation in heart failure patients?
502Are selective cyclo-oxygenase 2 inhibitors safe after coronary artery bypass grafting surgery?
504Can ST-segment recovery and myocardial blush predict prognosis?
506Do the beneficial effects of sirolimus-eluting stents extend beyond 1 year?
508Can vitamin E prevent cardiovascular events and cancer?
510Top of page
Reviews
Rate versus rhythm control in the management of patients with atrial fibrillation
514doi:10.1038/ncpcardio0320 | Full Text | PDF (134K)
Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?
522doi:10.1038/ncpcardio0323 | Full Text | PDF (266K)
Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke
529doi:10.1038/ncpcardio0321 | Full Text | PDF (256K)
Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart
536doi:10.1038/ncpcardio0319 | Full Text | PDF (481K)
Top of page
Case Study

Biventricular assist device placement and immunosuppression as therapy for necrotizing eosinophilic myocarditis
544doi:10.1038/ncpcardio0322 | Full Text | PDF (336K)



